PLx Pharma Inc.’s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August Shelf space for all three SKUs of VAZALORE is being reserved with ‘Coming Soon’ shelf placeholders
July 19, 2021 17:00 ET | Source: PLx Pharma Inc. PLx Pharma Inc. Sparta, New Jersey, UNITED STATES
SPARTA, N.J., July 19, 2021 (GLOBE NEWSWIRE) PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products, with its lead products VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”), today announced that three stock-keeping units (“SKUs”) of VAZALORE, the first and only U.S. Food and Drug Administration (“FDA”) approved liquid-filled aspirin capsules, will be available in over 8,000 Walgreens stores nationwide later in Augus
Natasha-giordano
Lisam-wilson
Walgreens
Drug-administration
Plx-pharma-inc
Site-communications-inc
Walgreen
Globe-newswire-plx-pharma-inc
Nasdaq
Chief-executive-officer
In-site-communications
நடாஷா-ஜியோர்டானோ